Evaluation of simplified treat and extend regimen using ranibizumab in exudative age related macular degeneration

Trial Profile

Evaluation of simplified treat and extend regimen using ranibizumab in exudative age related macular degeneration

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Aug 2014

At a glance

  • Drugs Ranibizumab (Primary)
  • Indications Age-related macular degeneration
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Jul 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan
    • 10 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top